Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (601-610 of 818) with videos related to

Pageof 82
Sort By:
Chromosoma|August 1, 1996
Molecular cytogenetic characterisation of the terminal heterochromatic segment of the B-chromosome of rye (Secale cereale)A Houben, R G Kynast, U Heim, et al.
Journal of Clinical Microbiology|August 9, 2003
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungiD J Diekema, S A Messer, R J Hollis, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolatesM A Pfaller, D J Diekema, S A Messer, et al.
Journal of Clinical Microbiology|November 1, 1994
Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centersH S Sader, M A Pfaller, F C Tenover, et al.
European Journal of Clinical Microbiology|June 1, 1984
In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centersA L Barry, L W Ayers, T L Gavan, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
In vitro evaluation of GR69153, a novel catechol-substituted cephalosporinM E Erwin, R N Jones, M S Barrett, et al.
Journal of Chemotherapy (Florence, Italy)|February 21, 2007
Re-evaluation of the role of broad-spectrum cephalosporins against staphylococci by applying contemporary in-vitro results and pharmacokinetic-pharmacodynamic principlesH S Sader, S M Bhavnani, P G Ambrose, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1993
In vitro comparison of E4868, a new trifluoroquinolone, with ciprofloxacin and temafloxacin tested against 5192 recent clinical isolates from five medical centersP R Murray, R N Jones, J A Washington, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1991
Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephemsR N Jones, M E Erwin, M S Barrett, et al.
The Journal of Antimicrobial Chemotherapy|September 6, 2007
Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulationT P Lodise, R Nau, M Kinzig, et al.
Pageof 82

Showing results (601-610 of 818) with videos related to

Sort By:
Pageof 82
Chromosoma|August 1, 1996
Molecular cytogenetic characterisation of the terminal heterochromatic segment of the B-chromosome of rye (Secale cereale)A Houben, R G Kynast, U Heim, et al.
Journal of Clinical Microbiology|August 9, 2003
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungiD J Diekema, S A Messer, R J Hollis, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolatesM A Pfaller, D J Diekema, S A Messer, et al.
Journal of Clinical Microbiology|November 1, 1994
Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centersH S Sader, M A Pfaller, F C Tenover, et al.
European Journal of Clinical Microbiology|June 1, 1984
In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centersA L Barry, L W Ayers, T L Gavan, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
In vitro evaluation of GR69153, a novel catechol-substituted cephalosporinM E Erwin, R N Jones, M S Barrett, et al.
Journal of Chemotherapy (Florence, Italy)|February 21, 2007
Re-evaluation of the role of broad-spectrum cephalosporins against staphylococci by applying contemporary in-vitro results and pharmacokinetic-pharmacodynamic principlesH S Sader, S M Bhavnani, P G Ambrose, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1993
In vitro comparison of E4868, a new trifluoroquinolone, with ciprofloxacin and temafloxacin tested against 5192 recent clinical isolates from five medical centersP R Murray, R N Jones, J A Washington, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1991
Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephemsR N Jones, M E Erwin, M S Barrett, et al.
The Journal of Antimicrobial Chemotherapy|September 6, 2007
Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulationT P Lodise, R Nau, M Kinzig, et al.
Pageof 82